| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.5 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.5 |